Paracetamolo Mylan Italia (Paracetamol)

Paracetamolo Mylan Italia is an oral analgesic that works within the pain and fever pathways.

• Pain: provides relief from mild to moderate nociceptive pain.
• Fever: lowers elevated body temperature associated with infectious or inflammatory processes.
• Headache: alleviates tension‑type and migraine‑associated head pain.
• Musculoskeletal discomfort: reduces discomfort from strains, sprains and minor injuries.

• Paracetamol exerts its effect primarily by inhibiting cyclooxygenase enzymes (COX‑1 and COX‑2) in the central nervous system, which leads to decreased synthesis of prostaglandins involved in pain signaling and thermoregulation. This central action reduces the perception of pain and lowers hypothalamic set‑point temperature without significant peripheral anti‑inflammatory activity.

Paracetamolo Mylan Italia is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Nausea: mild stomach upset reported by some users.
• Skin rash: occasional mild erythema or itching.
• Elevated liver enzymes: transient increase detectable in laboratory tests.
• Headache: paradoxical headache in rare cases.
• Dyspepsia: mild indigestion or discomfort.

Serious or Rare Side Effects

• Hepatotoxicity: severe liver injury, especially with overdose or chronic high‑dose use.
• Stevens‑Johnson syndrome or toxic epidermal necrolysis: rare severe skin reactions.
• Anaphylaxis: extremely rare systemic allergic response.
• Blood dyscrasias: rare cases of agranulocytosis or thrombocytopenia.
• Renal impairment: potential worsening of kidney function with prolonged high doses.

When using Paracetamolo Mylan Italia, consider the following safety measures.

• Assess liver function: avoid use in patients with severe hepatic impairment.
• Avoid excessive alcohol: concurrent intake increases risk of liver injury.
• Do not exceed recommended daily dose: limit total intake to 4 g per day for adults.
• Use with caution in children: follow pediatric dosing guidelines and avoid use in infants under 2 months.
• Monitor for allergic reactions: discontinue if rash, swelling or breathing difficulty occurs.
• Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Paracetamolo Mylan Italia may interact with other medicines; awareness of these interactions helps maintain safety.

Major Interactions (Avoid)

• Concurrent hepatotoxic drugs (e.g., isoniazid, methotrexate): increased risk of liver damage.
• Alcohol consumption: synergistic hepatotoxic effect.
• Warfarin: may enhance anticoagulant effect and increase INR.

Moderate Interactions (Monitor Closely)

• Carbamazepine: may reduce analgesic efficacy by increasing metabolism.
• Rifampicin: induces hepatic enzymes, potentially lowering plasma levels.
• Phenobarbital: may increase clearance, reducing effectiveness.
• Phenytoin: can alter paracetamol metabolism, requiring monitoring.
• Oral contraceptives: may slightly increase hepatic enzyme activity, warranting observation.